Bausch Health Companies Inc. (BHC) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Bausch Health Companies’s revenue went from $9.7B in fiscal 2016 to $10.3B in fiscal 2025, growth of about 0.7% a year.
Net income in fiscal 2025 was $157M, a net margin of 1.5%; the best year in this period was 2017 with $2.4B.
Over the twelve months to September 30, 2026, revenue was $11.1B and net income -$841M.
Free cash flow was $1.0B in fiscal 2025 and positive in 9 of the 10 years shown.
The diluted share count rose 8% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.1B | $10.3B | $9.6B | $8.8B | $8.1B | $8.4B | $8.0B | $8.6B | $8.4B | $8.7B | $9.7B |
| Gross profit | — | — | — | — | — | — | — | — | — | $6.2B | $7.1B |
| Operating income | $1.2B | $1.8B | $1.5B | $963M | $454M | $450M | $676M | -$203M | -$2.4B | $102M | -$566M |
| Net income | -$841M | $157M | -$46M | -$592M | -$225M | -$948M | -$560M | -$1.8B | -$4.1B | $2.4B | -$2.4B |
| EPS (diluted) | $-2.29 | $0.42 | $-0.13 | $-1.62 | $-0.62 | $-2.64 | $-1.58 | $-5.08 | $-11.81 | $6.83 | $-6.94 |
| R&D | $638M | $629M | $616M | $604M | $529M | $465M | $452M | $471M | $413M | $361M | $421M |
| Revenue growth | — | +6.7% | +9.9% | +7.8% | −3.7% | +5.1% | −6.7% | +2.6% | −3.9% | −9.8% | −7.4% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.2B | $1.4B | $1.6B | $1.0B | -$728M | $1.4B | $1.1B | $1.5B | $1.5B | $2.3B | $2.1B |
| Capital spending | -$344M | -$397M | -$337M | -$215M | -$218M | -$269M | -$302M | -$270M | -$157M | -$171M | -$235M |
| Free cash flow | $1.9B | $1.0B | $1.3B | $817M | -$946M | $1.2B | $809M | $1.2B | $1.3B | $2.1B | $1.9B |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — | — | — | $0 | $0 |
| Stock-based pay | $242M | $216M | $150M | $132M | $126M | $128M | $105M | $102M | $87M | $87M | $165M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $1.3B | $1.2B | $947M | $564M | $582M | $605M | $3.2B | $721M | $720M | $542M |
| Debt | — | $21.0B | $21.8B | $22.6B | $21.0B | $22.9B | $24.2B | $26.2B | $24.6B | $25.4B | $29.8B |
| Equity | — | -$554M | -$1.3B | -$1.0B | -$692M | -$106M | $535M | $1.1B | $2.7B | $5.8B | $3.2B |
| Total assets | — | $26.4B | $26.5B | $27.4B | $25.7B | $29.2B | $31.2B | $33.9B | $32.5B | $37.5B | $43.5B |
| Shares (diluted) | 381M | 375M | 368M | 365M | 362M | 359M | 355M | 352M | 351M | 352M | 347M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | — | — | 71.3% | 73.4% |
| Operating margin | 11.2% | 17.7% | 16.1% | 11.0% | 5.6% | 5.3% | 8.4% | -2.4% | -28.4% | 1.2% | -5.9% |
| Net margin | -7.6% | 1.5% | -0.5% | -6.8% | -2.8% | -11.2% | -7.0% | -20.8% | -49.5% | 27.6% | -24.9% |
| FCF margin | 16.8% | 9.8% | 13.1% | 9.3% | -11.6% | 13.7% | 10.1% | 14.3% | 16.0% | 24.3% | 19.1% |
| ROIC | — | 7.0% | 5.9% | 3.5% | 1.8% | 1.8% | 1.6% | -0.7% | -8.7% | 0.3% | -1.7% |
| ROE | — | -28.3% | 3.6% | 57.9% | 32.5% | 894.3% | -104.7% | -168.2% | -151.8% | 41.1% | -76.4% |
Frequently asked questions
What is Bausch Health Companies’s annual revenue?
$10.3B in fiscal 2025 and $11.1B over the twelve months to September 30, 2026.
How much profit does Bausch Health Companies make?
Net income was $157M in fiscal 2025 (net margin 1.5%).
Is Bausch Health Companies’s revenue growing?
Yes: revenue rose 6.7% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.